22,228
edits
Changes
Jump to navigation
Jump to search
m
Fixed date format error. Updated refs.
On the 10 June 2011, the OIG published its results from an audit of a contract between the National Institute of Allergy and Infectious Diseases (NIAID) and the University of California at San Francisco, which read in part:<ref>{{REFweb
| last= | first= | date=June 2011-06 | title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract N01-AI-15416 With the University of California at San Francisco Audit (A-03-10-03120) | url=http://oig.hhs.gov/oas/reports/region3/31003120.pdf | accessdate=2011-06-25
}}</ref>
On the 21 September 2011, the OIG published it's results from two separate audits of NIAID contracts with Avecia Biologics Limited and NexBio, Inc. The reports read in part:<ref>{{REFweb
| last= | first= | date=September 2011-09 | title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract N01-AI-3-0052 With Avecia Biologics Limited | url=http://oig.hhs.gov/oas/reports/region3/31003117.pdf | accessdate=2011-10-09
}}</ref><ref>{{REFweb
| last= | first= | date=September 2011-09 | title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract HHSN266-2006-00015C With NexBio, Inc. | url=http://oig.hhs.gov/oas/reports/region3/31003119.pdf | accessdate=2011-10-09
}}</ref>
On the 31 October 2011, the OIG published it's results from an audit of a contract between NIAID and the EMMES Corporation, which read in part:<ref>{{REFweb
| last= | first= | date=October 2011-10 | title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract HHSN272-2008-00013C with the EMMES Corporation (A-03-10-03115) | url=http://oig.hhs.gov/oas/reports/region3/31003115.pdf | accessdate=2011-09-11
}}</ref>
On the 14 September 2012, the OIG published it's results from two separate audits of NIAID contracts with PPD Development, LP. The reports read in part:<ref>{{REFweb
| last= | first= | date=September 2012-09 | title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract HHSN266-2005-00022C With PPD Development, LP (Audit A-03-10-03118) | url=http://oig.hhs.gov/oas/reports/region3/31003118.pdf | accessdate=2012-09-26
}}</ref><ref>{{REFweb
| last= | first= | date=September 2012-09 | title=Appropriations Funding for National Institute of Allergy and Infectious Diseases Contract N01-AI-30068 With PPD Development, LP (Audit A-03-10-03116) | url= http://oig.hhs.gov/oas/reports/region3/31003116.pdf | accessdate=2011-09-26
}}</ref>
== Office of Inspector General (OIG) investigations of NICHD commercial partnerships ==
On the 17 October 2011, the OIG published it's results from an audit of a contract between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and Westat, Inc., which read in part:<refname="A-03-10-03106">{{REFweb | last= | first= | date=October 2011-10 | title=Appropriations Funding for Eunice Kennedy Shriver National Institute of Child Health and Human Development Contract HHSN275-03-3345 With Westat, Inc. Audit (A-03-10-03106) | url=http://oig.hhs.gov/oas/reports/region3/31003106.pdf | accessdate=2011-11-20
}}</ref>
}}
Background information:<ref>{{REFweb | lastname= | first= | date=October 2011 | title=Appropriations Funding for Eunice Kennedy Shriver National Institute of Child Health and Human Development Contract HHSN275-03-3345 With Westat, Inc. Audit ("A-03-10-03106) | url=http://oig.hhs.gov/oas/reports/region3/31003106.pdf | accessdate=2011-11-20}}<"/ref>
{{Citation
| Title= | Text=On November 1, 2002, NICHD awarded contract HHSN275-03-3345 (the Contract), totaling $164.7 million, to Westat, Inc. (Westat), in Rockville, Maryland. The Contract required Westat to establish an international pediatric and perinatal HIV studies network-coordinating center to maintain, coordinate, and manage a network of clinical centers. These clinical centers, under subcontracts with Westat, conducted research on the treatment, prevention, diagnosis, epidemiology, and natural history of HIV infection and disease in pediatric, adolescent, and maternal patient populations. | Author= | Source=| lang=| before=| after=| Transcription=| Translation=
}}
On the 26 October 2011, the OIG published it's results from an audit of a contract between the National Institute on Drug Abuse (NIDA) and Charles River Laboratories, Inc., which read in part:<ref>{{REFweb
| last= | first= | date=October 2011-10 | title=Appropriations Funding for National Institute on Drug Abuse Contract HHSN271-2007-00009C with Charles River Laboratories, Inc. (A-03-10-03104) | url=http://oig.hhs.gov/oas/reports/region3/31003104.pdf | accessdate=2011-11-22
}}</ref>
On the 20 December 2011, the OIG published a report critical of the NIH's administration of the Clinical and Translational Science Awards (CTSA) program.<ref>{{REFweb
| last= | first= | date=December 2011-12 | title=NIH Administration of the Clinical and Translational Science Awards Program (Report OEI-07-09-00300) | url=http://oig.hhs.gov/oei/reports/oei-07-09-00300.pdf | accessdate=2011-12-22
}}</ref> The report read in part:
== Weird Science ==
"NIH video reveals the science behind yoga"<ref>{{REFweb
| last=NIH | first= | date=August 2012-08 | title=NIH video reveals the science behind yoga | url=http://www.nih.gov/news/health/aug2012/nccam-01.htm | accessdate=2012-08-02
}}</ref>
== Continuing advocating for more circumcision ==
From a National HIV Vaccine Awareness Day statement dated 18 May 2011 by Anthony S. Fauci, M.D., Director of NIAID (emphasis added):<ref>{{REFweb
| last=Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health | first= | date=May 2011-05 | title=National HIV Vaccine Awareness Day May 18, 2011 Statement | url=http://www.niaid.nih.gov/news/newsreleases/2011/Pages/HVAD2011.aspx?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+aidsgovnews+%28AIDS.gov+News+and+Events%29 | accessdate=2011-06-25
}}</ref>